Company Filing History:
Years Active: 2010
Title: Ariel C Hollnshead: Innovator in Cancer Research
Introduction
Ariel C Hollnshead is a prominent inventor based in Charlotte Harbor, FL (US). She has made significant contributions to the field of cancer research, particularly in the development of monoclonal antibodies for treating colon and pancreatic cancers. Her work is vital in advancing therapeutic options for patients suffering from these diseases.
Latest Patents
Ariel holds a patent for "Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers." This invention provides purified or highly pure recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA). The patent also includes nucleic acid sequences encoding the antibody chains and the corresponding amino acid sequences, along with various uses for these sequences.
Career Highlights
Ariel is currently associated with Neogenix Oncology, Inc., where she continues her research and development efforts. Her innovative approach to cancer treatment has positioned her as a key figure in the oncology field.
Collaborations
Ariel collaborates with notable colleagues, including Myron Arlen and J Andrew Bristol, who contribute to her research initiatives and enhance the impact of her work.
Conclusion
Ariel C Hollnshead's contributions to cancer research through her innovative patents and collaborations highlight her dedication to improving patient outcomes. Her work exemplifies the importance of innovation in the medical field.